Anzeige
Mehr »
Login
Donnerstag, 26.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol: N/A
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.11.Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know7
21.11.CV Sciences to acquire Extract Labs in strategic expansion2
21.11.CV Sciences enters into agreement to acquire Extract Labs1
21.11.CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs80SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company...
► Artikel lesen
21.11.CV Sciences, Inc. - 8-K, Current Report-
CV SCIENCES Aktie jetzt für 0€ handeln
14.11.CV Sciences Q3: Revenue Stable Amid New Launches, Financing1
14.11.CV Sciences, Inc. - 10-Q, Quarterly Report-
14.11.CV Sciences Non-GAAP EPS of $0.00, revenue of $3.87M1
14.11.CV Sciences, Inc. Reports Third Quarter 2024 Financial Results80SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company...
► Artikel lesen
14.11.CV Sciences, Inc. - 8-K, Current Report-
13.08.CV Sciences, Inc. - 10-Q, Quarterly Report2
13.08.Earnings call: CV Sciences maintains revenue, eyes growth with acquisitions2
13.08.Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q22
13.08.CV Sciences, Inc. - 8-K, Current Report1
13.08.CV Sciences Non-GAAP EPS of $0.00, revenue of $3.95M2
13.08.CV Sciences, Inc. Reports Second Quarter 2024 Financial Results259SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
09.07.CV Sciences, Inc. - 8-K, Current Report2
14.05.CV Sciences, Inc. Reports First Quarter 2024 Financial Results171SAN DIEGO, May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
28.03.CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results220SAN DIEGO, March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1